Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 14       

   Table of Contents      
BOOK REVIEW
Year : 2012  |  Volume : 135  |  Issue : 1  |  Page : 142-143

Global tuberculosis control 2010


LRS Institute of TB & Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110 030, India

Date of Web Publication1-Mar-2012

Correspondence Address:
D Behera
LRS Institute of TB & Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110 030
India
Login to access the Email id


Get Permissions


How to cite this article:
Behera D. Global tuberculosis control 2010. Indian J Med Res 2012;135:142-3

How to cite this URL:
Behera D. Global tuberculosis control 2010. Indian J Med Res [serial online] 2012 [cited 2014 Apr 20];135:142-3. Available from: http://www.ijmr.org.in/text.asp?2012/135/1/142/93441

Global tuberculosis control 2010 (World Health Organization, Geneva). 2010. 211 pages. Price: CHF/US $ 40.00, in developing countries: CHF/US $ 28.00

ISBN 978-92-4-156406-9

The World Health Organization (WHO) has been publishing annual reports on global control of tuberculosis (TB) every year since 1997. The main purpose of the 2010 Report is to provide a comprehensive and up-to-date assessment of the TB epidemic and progress made in TB care and control at global, regional and country levels. This Report on global tuberculosis control was produced by a core team of 12 experts. Overall guidance was provided by the Director of the Stop TB Department, Mario Raviglione. Progress towards global targets set for 2015 is given particular attention. The target included in the millennium development goals (MDGs) is that TB incidence should be falling by 2015. The Stop TB Partnership has set two additional targets, which are to halve rates of prevalence and mortality by 2015 compared with their levels in 1990. Collectively, the WHO's Stop TB Strategy and the Stop TB Partnership's Global Plan to Stop TB have set out how the 2015 targets can be achieved.

This fifteenth Annual Report contains more up-to-date information than any previous Report in the series. The estimates of the global burden of disease caused by TB in 2009 were as follows: 9.4 million incident (new) cases (range 8.9-9.9 million), 14 million prevalent cases (range 12-16 million), 1.3 million deaths among HIV-negative people (range 1.2-1.5 million) and 0.38 million deaths among HIV-positive people (range 0.32 - 0.45 million). Most cases were in the South-East Asia, African and Western Pacific Regions (35, 30 and 20%, respectively). An estimated 11-13 per cent of incident cases were HIV-positive; the African Region accounted for approximately 80 per cent of these cases.

There were 5.8 million notified cases of TB in 2009, equivalent to a case detection rate (CDR) of 63 per cent (range 60-67%), up from 61 per cent in 2008. Of the 2.6 million patients with sputum smear-positive pulmonary TB in the 2008 cohort, 86 per cent were successfully treated. New and compelling data from 15 countries show that efforts by national TB programmes (NTPs) to engage all care providers in TB control (termed public-private mix, or PPM) can be a particularly effective way to increase the CDR. In areas where PPM was implemented, non-NTP providers accounted for around one-fifth to one-third of total notifications in 2009.

In 2009, 26 per cent of TB patients knew their HIV status (up from 22% in 2008), including 53 per cent of patients in the African Region. A total of 300,000 HIV-positive TB patients were enrolled on co-trimoxazole preventive therapy, and almost 140,000 were enrolled on anti-retroviral therapy (75 and 37%, respectively of those who tested HIV-positive). To prevent TB, almost 80,000 people living with HIV were provided with isoniazid preventive therapy. This is an increase from previous years, but still represents less than 1 per cent of the estimated number of people living with HIV worldwide.

Among TB patients notified in 2009, an estimated 250,000 (range 230,000-270,000) had multidrug-resistant TB (MDR-TB). Of these, slightly more than 30,000 (12%) were diagnosed with MDR-TB and notified. Diagnosis and treatment of MDR-TB need to be rapidly expanded.

Funding for TB control continues to increase and will reach almost US$ 5 billion in 2011. There is considerable variation in what countries spend on a per patient basis ( < US$ 100 to > 1000), and the extent to which countries rely on domestic or external sources of funds. Compared with the funding requirements estimated in the Global Plan, the funding gap is approximately US$ 1 billion in 2011. Given the scale-up of interventions set out in the Plan, this could increase to US$ 3 billion by 2015 without intensified efforts to mobilize more resources. Incidence rates are falling globally and in five of WHO's six Regions (the exception is the South-East Asia Region, where the incidence rate is stable). If these trends are sustained, the MDG target will be achieved. Mortality rates at global level fell by around 35 per cent between 1990 and 2009, and the target of a 50 per cent reduction by 2015 could be achieved if the current rate of decline is sustained. At the regional level, the mortality target could be achieved in five of WHO's six Regions; the exception is the African Region (although rates of mortality are falling). Prevalence is falling globally and in all six WHO Regions. The target of halving the 1990 prevalence rate by 2015 appears out of reach at global level, but could be achieved in three of six Regions: the Region of the Americas, the Eastern Mediterranean Region and the Western Pacific Region.

Reductions in the burden of disease achieved to date follow 15 years of intensive efforts to improve TB care and control. Between 1995 and 2009, a total of 41 million TB patients were successfully treated in DOTS programmes, and up to 6 million lives were saved including two million among women and children. Looking forward, the Stop TB Partnership launched an updated version of the Global Plan to Stop TB in October 2010, for the years 2011-2015. In the five years that remain until the target year of 2015, intensified efforts are needed to plan, finance and implement the Stop TB Strategy, according to the updated targets included in this Plan. This could save at least one million lives per year.

The book has 8 different sections including the Methods, Global burden of TB, Global targets, Stop TB Strategy and Global Plan to Stop TB, Progress in implementing the Stop TB Strategy and the Global Plan to Stop TB, Financing for TB control, Progress towards global targets for reductions in disease burden, Improving measurement of the global burden of TB and Conclusions. The three Annexures in the book contain Methods used to estimate the global burden of diseases caused by TB, Global, regional and country specific data for key indicators and Country profiles. The entire matter is also available online (www.who.int/tb/data).

In view of the updated data and the various strategies being adopted to control TB at the global level, it is a useful book /reference for physicians, TB specialists, epidemiologists, public health experts and administrators and policy makers.




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed363    
    Printed26    
    Emailed0    
    PDF Downloaded76    
    Comments [Add]    

Recommend this journal